• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4840107)   Today's Articles (10964)
For: Dalavaikodihalli Nanjaiah N, Ramaswamy P, Goswami K, Fathima K H, Borkotokey M. Survival of glioblastoma cells in response to endogenous and exogenous oxidative challenges: possible implication of NMDA receptor-mediated regulation of redox homeostasis. Cell Biol Int 2019;43:1443-1452. [PMID: 31187913 DOI: 10.1002/cbin.11193] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2019] [Accepted: 06/06/2019] [Indexed: 01/24/2023]
Number Cited by Other Article(s)
1
Knight Z, Ruiz A, Elies J. Piezoelectric Nanomaterials for Cancer Therapy: Current Research and Future Perspectives on Glioblastoma. J Funct Biomater 2025;16:114. [PMID: 40278222 PMCID: PMC12027790 DOI: 10.3390/jfb16040114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2024] [Revised: 03/11/2025] [Accepted: 03/21/2025] [Indexed: 04/26/2025]  Open
2
González-Cota AL, Martínez-Flores D, Rosendo-Pineda MJ, Vaca L. NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer. Cell Calcium 2024;119:102856. [PMID: 38408411 DOI: 10.1016/j.ceca.2024.102856] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Revised: 01/08/2024] [Accepted: 02/07/2024] [Indexed: 02/28/2024]
3
Wang J, Chen S, Xiang W, Zhu Q, Ren N. NRF1 Alleviated Oxidative Stress of Glioblastoma Cells by Regulating NOR1. Folia Biol (Praha) 2023;69:13-21. [PMID: 37962027 DOI: 10.14712/fb2023069010013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2023]
4
NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells. J Neurooncol 2022;160:375-388. [DOI: 10.1007/s11060-022-04154-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2022] [Accepted: 09/29/2022] [Indexed: 11/25/2022]
5
Cheng B, Hong X, Wang L, Cao Y, Qin D, Zhou H, Gao D. Curzerene suppresses progression of human glioblastoma through inhibition of glutathione S-transferase A4. CNS Neurosci Ther 2022;28:690-702. [PMID: 35048517 PMCID: PMC8981481 DOI: 10.1111/cns.13800] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2021] [Revised: 10/26/2021] [Accepted: 01/01/2022] [Indexed: 12/18/2022]  Open
6
Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma. Antioxidants (Basel) 2021;10:1988. [PMID: 34943091 PMCID: PMC8750785 DOI: 10.3390/antiox10121988;] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]  Open
7
Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma. Antioxidants (Basel) 2021;10:antiox10121988. [PMID: 34943091 PMCID: PMC8750785 DOI: 10.3390/antiox10121988] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2021] [Revised: 12/06/2021] [Accepted: 12/08/2021] [Indexed: 11/17/2022]  Open
8
Turkez H, Arslan ME, Tatar A, Mardinoglu A. Promising potential of boron compounds against Glioblastoma: In Vitro antioxidant, anti-inflammatory and anticancer studies. Neurochem Int 2021;149:105137. [PMID: 34293392 DOI: 10.1016/j.neuint.2021.105137] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Revised: 07/06/2021] [Accepted: 07/08/2021] [Indexed: 12/20/2022]
9
Olivier C, Oliver L, Lalier L, Vallette FM. Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Front Mol Biosci 2021;7:620677. [PMID: 33585565 PMCID: PMC7873048 DOI: 10.3389/fmolb.2020.620677] [Citation(s) in RCA: 100] [Impact Index Per Article: 25.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Accepted: 12/08/2020] [Indexed: 12/26/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA